<img height="1" width="1" style="display:none;" alt="" src="https://dc.ads.linkedin.com/collect/?pid=412980&amp;fmt=gif">
LSX-Blog.png

Something Powerful

Tell The Reader More

The headline and subheader tells us what you're offering, and the form header closes the deal. Over here you can explain why your offer is so great it's worth filling out a form for.

Remember:

  • Bullets are great
  • For spelling out benefits and
  • Turning visitors into leads.

Series A Spotlight: Q&A with Protembis’ Conrad Ras...

In October 2018, German medical device company Protembis closed an oversubs...

Read More

Addex prepares PD-LID programme for 2019 Phase 3 r...

Key findings: Switzerland-based Addex Therapeutics is preparing its lead ca...

Read More

Investorview: Propelling life science innovation f...

Denmark’s Novo Seeds was established in 2007 in order to identify promising...

Read More

Gates Foundation funding for DelSiTech’s silica-ba...

Key learnings: DelSiTech has been awarded significant grant funding from th...

Read More

Lifestars Awards 2018 celebrate life science succe...

LSX (formerly Biotech and Money) hosted the Lifestars Awards at the Honoura...

Read More

€79m Series C pushes Galecto Biotech’s pipeline in...

Key learnings: Ysios Capital and OrbiMed led Galecto Biotech’s €79 million ...

Read More

Driving developments to defeat ageing: Q&A with Au...

In February 2019, key stakeholders in the growing longevity industry will c...

Read More

Rethinking the growth capital challenge in UK life...

Investors, entrepreneurs and deal makers in the UK life sciences industry m...

Read More

Artios Pharma’s £65m Series B to spur development ...

Key findings:

Read More

Have your say on life sciences investment trends

LSX, formerly Biotech and Money, is conducting the 3rd Investor Perception ...

Read More

Forendo Pharma receives €4m boost to progress wome...

Key learnings: Vesalius BioCapital III Partners invested €4 million in Finl...

Read More

Evox Therapeutics raises £35.5m Series B to advanc...

Key learnings: UK biotech Evox Therapeutics recently announced its £35.5 mi...

Read More

Add Your Response